8-KThe WireRoutine
Shareholder Vote · Company Update
Filed Jun 22, 2026 · 7d ago · Accession 0001628280-26-044618
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Allogene Therapeutics, Inc.
- Ticker
- ALLO
- CIK
- 1737287
- Form type
- 8-K
- Filing date
- Jun 22, 2026
- Report date
- Jun 18, 2026
- Document
- allo-20260618.htm
- Size
- 216 KB